MAPT and Alzheimer disease: The measurement of amyloid-beta (Aβ), total tau (tTau), and phosphorylated tau at threonine 181 (pTau) in the cerebrospinal fluid (CSF) are now implemented in many clinics to support AD diagnosis [3].